These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 32041852
1. The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study. Rukuni R, Gregson C, Kahari C, Kowo F, McHugh G, Munyati S, Mujuru H, Ward K, Filteau S, Rehman AM, Ferrand R. BMJ Open; 2020 Feb 09; 10(2):e031792. PubMed ID: 32041852 [Abstract] [Full Text] [Related]
2. Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe. Rukuni R, Rehman AM, Mukwasi-Kahari C, Madanhire T, Kowo-Nyakoko F, McHugh G, Filteau S, Chipanga J, Simms V, Mujuru H, Ward KA, Ferrand RA, Gregson CL. Lancet Child Adolesc Health; 2021 Aug 09; 5(8):569-581. PubMed ID: 34139202 [Abstract] [Full Text] [Related]
3. Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe. Gregson CL, Hartley A, Majonga E, McHugh G, Crabtree N, Rukuni R, Bandason T, Mukwasi-Kahari C, Ward KA, Mujuru H, Ferrand RA. Bone; 2019 Aug 09; 125():96-102. PubMed ID: 31082498 [Abstract] [Full Text] [Related]
4. Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe. Gregson CL, Rehman AM, Rukuni R, Mukwasi-Kahari C, Madanhire T, Kowo-Nyakoko F, Breasail MÓ, Jeena L, Mchugh G, Filteau S, Chipanga J, Simms V, Mujuru H, Ward KA, Ferrand RA. AIDS; 2024 May 01; 38(6):853-863. PubMed ID: 37991523 [Abstract] [Full Text] [Related]
5. Impaired Bone Architecture in Peripubertal Children With HIV, Despite Treatment With Antiretroviral Therapy: A Cross-Sectional Study From Zimbabwe. Mukwasi-Kahari C, Rehman AM, Ó Breasail M, Rukuni R, Madanhire T, Chipanga J, Stranix-Chibanda L, Micklesfield LK, Ferrand RA, Ward KA, Gregson CL. J Bone Miner Res; 2023 Feb 01; 38(2):248-260. PubMed ID: 36426511 [Abstract] [Full Text] [Related]
6. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression. Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T, Bone-D Study Group. HIV Med; 2017 Apr 01; 18(4):235-244. PubMed ID: 27477214 [Abstract] [Full Text] [Related]
7. Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial. Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA, VITALITY team. Trials; 2024 Jul 22; 25(1):499. PubMed ID: 39039558 [Abstract] [Full Text] [Related]
8. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial. Natukunda E, Szubert A, Otike C, Namyalo I, Nambi E, Bamford A, Doerholt K, Gibb DM, Musiime V, Musoke P. PLoS One; 2023 Jul 22; 18(7):e0288877. PubMed ID: 37471330 [Abstract] [Full Text] [Related]
9. Fracture prevalence and its association with bone density among children living with HIV in Zimbabwe. Rukuni R, Simms V, Rehman AM, Mukwasi-Kahari C, Mujuru H, Ferrand RA, Gregson CL. AIDS; 2023 Apr 01; 37(5):759-767. PubMed ID: 36728418 [Abstract] [Full Text] [Related]
10. Bone mineral density in children and adolescents with perinatal HIV infection. DiMeglio LA, Wang J, Siberry GK, Miller TL, Geffner ME, Hazra R, Borkowsky W, Chen JS, Dooley L, Patel K, van Dyke RB, Fielding RA, Gurmu Y, Jacobson DL, Pediatric HIVAIDS Cohort Study (PHACS). AIDS; 2013 Jan 14; 27(2):211-20. PubMed ID: 23032412 [Abstract] [Full Text] [Related]
11. The impact of HIV infection on skeletal maturity in peripubertal children in Zimbabwe: a cross-sectional study. Kowo-Nyakoko F, Gregson CL, Westbury LD, Madanhire T, Offiah AC, Micklesfield LK, Ferrand RA, Rehman AM, Ward KA. BMC Pediatr; 2024 Jul 27; 24(1):480. PubMed ID: 39068422 [Abstract] [Full Text] [Related]
12. Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial. Dzavakwa NV, Chisenga M, McHugh G, Filteau S, Gregson CL, Kasonka L, Kranzer K, Mabuda HB, Mujuru H, Redzo N, Rowland-Jones S, Schaible UE, Simms V, Ferrand RA, VITALITY team. Trials; 2022 Jan 26; 23(1):78. PubMed ID: 35081986 [Abstract] [Full Text] [Related]
13. Association Between Vitamin D Insufficiency and Impaired Bone Density Among Adolescents With Perinatally Acquired HIV Infection. Dzavakwa NV, Simms V, Gregson CL, Chisenga M, Filteau S, Kasonka L, Kranzer K, Banda-Mabuda H, Mujuru H, Redzo N, Mukwasi-Kahari C, Rowland-Jones SL, Schaible UE, Ferrand RA, VITALITY team . Open Forum Infect Dis; 2024 Sep 26; 11(9):ofae442. PubMed ID: 39301108 [Abstract] [Full Text] [Related]
14. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men. Paccou J, Viget N, Drumez E, Cortet B, Robineau O. Med Mal Infect; 2018 Oct 26; 48(7):442-448. PubMed ID: 29699830 [Abstract] [Full Text] [Related]
15. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. Carr A, Grund B, Neuhaus J, Schwartz A, Bernardino JI, White D, Badel-Faesen S, Avihingsanon A, Ensrud K, Hoy J, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group. HIV Med; 2015 Apr 26; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332 [Abstract] [Full Text] [Related]
16. Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. Mulligan K, Harris DR, Emmanuel P, Fielding RA, Worrell C, Kapogiannis BG, Monte D, Sleasman J, Wilson CM, Aldrovandi GM, ATN 021 Protocol team. Clin Infect Dis; 2012 Aug 26; 55(3):461-8. PubMed ID: 22573848 [Abstract] [Full Text] [Related]
17. Relative contribution of HIV infection, demographics and body mass index to bone mineral density. Cotter AG, Sabin CA, Simelane S, Macken A, Kavanagh E, Brady JJ, McCarthy G, Compston J, Mallon PW, HIV UPBEAT Study Group. AIDS; 2014 Sep 10; 28(14):2051-60. PubMed ID: 25265073 [Abstract] [Full Text] [Related]
18. Musculoskeletal health in newly diagnosed children with Crohn's disease. Ward LM, Ma J, Rauch F, Benchimol EI, Hay J, Leonard MB, Matzinger MA, Shenouda N, Lentle B, Cosgrove H, Scharke M, Konji VN, Mack DR. Osteoporos Int; 2017 Nov 10; 28(11):3169-3177. PubMed ID: 28791436 [Abstract] [Full Text] [Related]
19. Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements. Pitukcheewanont P, Safani D, Church J, Gilsanz V. Osteoporos Int; 2005 Nov 10; 16(11):1393-6. PubMed ID: 15702261 [Abstract] [Full Text] [Related]
20. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial. Hoy JF, Grund B, Roediger M, Schwartz AV, Shepherd J, Avihingsanon A, Badal-Faesen S, de Wit S, Jacoby S, La Rosa A, Pujari S, Schechter M, White D, Engen NW, Ensrud K, Aagaard PD, Carr A, INSIGHT START Bone Mineral Density Substudy Group. J Bone Miner Res; 2017 Sep 10; 32(9):1945-1955. PubMed ID: 28650589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]